鎮痛剤の世界市場レポート 2024

鎮痛剤の市場規模は、今後数年間で着実に成長すると予想されています。2028年には3.7%の年間複合成長率（CAGR）で1,281億8,000万米ドルに成長すると予想されます。鎮痛剤市場の予測期間で予想される成長は、疼痛管理代替品への注目の高まり、市場競争の激化、消費者の健康意識の高まり、ヘルスケアニーズに影響を与える人口動態の変化、慢性疾患の有病率の上昇などの要因に起因すると考えられます。予測期間に予想される主な動向には、疼痛管理における個別化医療の採用、非オピオイド代替品の重視、CBDとカンナビノイドの使用、標的を絞った疼痛管理アプローチへの移行、そして疼痛救済ソリューションの利用しやすさと手頃な価格の向上への焦点が含まれます。

鎮痛剤市場は、慢性疾患の有病率の顕著な増加により、大幅な成長を遂げています。非感染性疾患（NCD）としても知られる慢性疾患は、遺伝的、生理的、環境的、行動的要因の組み合わせにより長期間にわたって発症します。世界保健機関（WHO）の2022年9月の報告書によると、NCDは世界の死亡者数の74%を占め、年間合計4,100万人が死亡しています。これらの病気により、毎年1,700万人が70歳未満で早死にしており、その86%が低・中所得国で発生しています。これらの薬剤はさまざまな病状に伴う重度の痛みを効果的に治療し、軽減するため、慢性疾患の有病率の拡大は、鎮痛剤市場の拡大を促進する重要な要因となっています。

鎮痛剤市場の成長は、ヘルスケア費の増加によってさらに促進されます。ヘルスケア費には、医療サービス、家族計画、栄養プログラム、緊急支援に関連するすべての費用が含まれます。ヘルスケア支出の増加は製薬業界の研究開発を刺激し、新しく改良された鎮痛剤の革新につながります。英国国家統計局の2023年5月の報告書によると、2020年から2021年にかけて英国のヘルスケア支出は名目9.4%、実質9.7%増加しました。2021年のヘルスケア支出総額は3兆4,490億米ドルへ修正（2,807億ポンド）に達し、これは1人当たり5,147米ドル（4,188ポンド）に相当します。このヘルスケア支出の急増は、鎮痛剤市場の成長の促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の鎮痛剤市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の鎮痛剤市場規模実績と成長、2018年～2023年
• 世界の鎮痛剤市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の鎮痛剤市場、タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 非オピオイド
• オピオイド
• 世界の鎮痛剤市場、流通チャネル別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院薬局
• 小売薬局
• ドラッグストア
• 世界の鎮痛剤市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 内服鎮痛剤
• 外用鎮痛剤

第7章 地域と国の分析

• 世界の鎮痛剤市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の鎮痛剤市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鎮痛剤市場の競合情勢
• 鎮痛剤市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson Services Inc.
  • Medley Pharmaceuticals Limited
  • AbbVie Inc.
  • Bayer HealthCare Pharmaceuticals LLC

第31章 その他の大手と革新的な企業

• Novartis International AG
• Sanofi SA
• Bristol-Myers Squibb Co.
• AstraZeneca Plc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical company Limited
• Eli Lilly and Company
• Becton Dickinson and Company
• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals Industries Ltd.
• Boston Scientific Corporation
• Sun Pharmaceutical Industries Limited
• Purdue Pharma LP

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Analgesics are medications used to alleviate pain, including conditions such as musculoskeletal pain, surgical pain, trauma-induced pain, and cancer-related pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone.

The main types of analgesics are non-opioids and opioids. Non-opioid analgesics are pain relievers available over-the-counter (OTC) and by prescription. They are increasingly promoted as a desirable, safe, and effective first-line therapeutic option in various clinical settings for managing mild to severe acute and chronic pain. Analgesics come in different forms, including prescription analgesics and over-the-counter (OTC) analgesics, with various routes of administration such as oral, intravenous, rectal, transdermal, and topical. They are used both internally (internal analgesics) and externally (external analgesics) and are distributed through channels such as hospital pharmacies, retail pharmacies, and drug stores.

The analgesics market research report is one of a series of new reports from The Business Research Company that provides analgesics market statistics, including analgesics industry global market size, regional shares, competitors with an analgesics market share, detailed analgesics market segments, market trends, and opportunities, and any further data you may need to thrive in the analgesics industry. This analgesics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The analgesics market size has grown steadily in recent years. It will grow from $106.57 billion in 2023 to $110.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.9%. The growth observed during the historical period in the analgesics market can be attributed to factors such as the impact of alternative therapies, studies on the safety and efficacy of analgesics, the prevalence of pain-related conditions, marketing and promotional efforts, and economic factors influencing the demand for pain relief medications.

The analgesics market size is expected to see steady growth in the next few years. It will grow to $128.18 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The anticipated growth in the forecast period in the analgesics market can be attributed to factors such as the increasing focus on pain management alternatives, intensified market competition, growing consumer health awareness, demographic shifts influencing healthcare needs, and the rising prevalence of chronic diseases. Major trends expected in the forecast period include the adoption of personalized medicine in pain management, the emphasis on non-opioid alternatives, the usage of CBD and cannabinoids, a move towards targeted pain management approaches, and a focus on enhancing accessibility and affordability of pain relief solutions.

The analgesics market is experiencing significant growth, driven by a notable increase in the prevalence of chronic diseases. Chronic diseases, also known as noncommunicable diseases (NCDs), develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral factors. According to a September 2022 report from the World Health Organization (WHO), NCDs account for 74% of global fatalities, totaling 41 million deaths annually. These diseases result in 17 million premature deaths each year before the age of 70, with 86% occurring in low- and middle-income nations. The escalating prevalence of chronic diseases is a key factor fueling the expansion of the analgesics market as these drugs effectively treat and alleviate severe pain associated with various medical conditions.

The growth of the analgesics market is further propelled by an increase in healthcare expenditures. Healthcare expenditures encompass all costs related to health services, family planning, nutrition programs, and emergency assistance. Higher healthcare spending stimulates research and development in the pharmaceutical industry, leading to the innovation of new and improved analgesic drugs. A May 2023 report from the UK's Office for National Statistics reveals a 9.4% nominal and 9.7% real increase in healthcare spending between 2020 and 2021 in the UK. The total healthcare expenditure in 2021 reached $3449 billion (£280.7 billion), equivalent to $5,147 per person (£4,188). This surge in healthcare spending is a driving force behind the growth of the analgesics market.

The expansion of the analgesics market faces constraints due to the rising utilization of biologics for treating inflammatory and neuropathic pain. Biologics, derived from living organisms, often offer greater efficacy compared to analgesics, which only provide effective pain relief to approximately 50% of patients. This shift towards biologics, exemplified by FDA approval for Pfizer and Lilly's Tanezumab, poses a challenge to the analgesics market's growth.

Companies in the analgesics market are strategically investing to foster growth. Leading manufacturers are channeling investments into clinical-stage companies to enhance their market position and gain a competitive edge. In January 2022, Concentric Analgesics, Inc., secured $20 million in convertible note financing to advance the Phase 3 development of Vocacapsaicin, its lead product candidate for post-surgical pain. Such investments allow companies to expand geographically and attain specialized expertise in research and development, strengthening their overall competitiveness.

In October 2021, Pacira BioSciences Inc., a pharmaceutical company based in the United States, finalized the acquisition of Flexion Therapeutics for a total of $630 million. This strategic move is anticipated to facilitate Pacira BioSciences Inc. in broadening its foothold within the realm of non-opioid pain management, allowing the company to offer comprehensive non-opioid solutions throughout the neural pain pathway. Flexion Therapeutics, a biotechnology company based in the United States, specialized in the exploration, development, and commercialization of anti-inflammatory and analgesic drugs.

Major companies operating in the analgesics market report are Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Becton Dickinson and Company, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

North America was the largest region in the analgesics market in 2023. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the analgesics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The analgesics market consists of sales of codeine, hydrocodone, oxycodone, and methadone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Analgesics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on analgesics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for analgesics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The analgesics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Non-opioids; Opioids
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores
• 3) By Application: Internal Analgesics; External Analgesics

Sub-Segments-

• By Route of Administration: Oral; Intravenous; Rectal; Transdermal; Topical
• By Drug Type: Prescription Analgesics; OTC Analgesics
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Medley Pharmaceuticals Limited; AbbVie Inc.; Bayer HealthCare Pharmaceuticals LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Analgesics Market Characteristics

3. Analgesics Market Trends And Strategies

4. Analgesics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Analgesics Market Size and Growth

• 5.1. Global Analgesics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Analgesics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Analgesics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Analgesics Market Segmentation

• 6.1. Global Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Non-opioids
• Opioids
• 6.2. Global Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• 6.3. Global Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Internal Analgesics
• External Analgesics

7. Analgesics Market Regional And Country Analysis

• 7.1. Global Analgesics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Analgesics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Analgesics Market

• 8.1. Asia-Pacific Analgesics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Analgesics Market

• 9.1. China Analgesics Market Overview
• 9.2. China Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Analgesics Market

• 10.1. India Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Analgesics Market

• 11.1. Japan Analgesics Market Overview
• 11.2. Japan Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Analgesics Market

• 12.1. Australia Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Analgesics Market

• 13.1. Indonesia Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Analgesics Market

• 14.1. South Korea Analgesics Market Overview
• 14.2. South Korea Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Analgesics Market

• 15.1. Western Europe Analgesics Market Overview
• 15.2. Western Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Analgesics Market

• 16.1. UK Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Analgesics Market

• 17.1. Germany Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Analgesics Market

• 18.1. France Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Analgesics Market

• 19.1. Italy Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Analgesics Market

• 20.1. Spain Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Analgesics Market

• 21.1. Eastern Europe Analgesics Market Overview
• 21.2. Eastern Europe Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Analgesics Market

• 22.1. Russia Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Analgesics Market

• 23.1. North America Analgesics Market Overview
• 23.2. North America Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Analgesics Market

• 24.1. USA Analgesics Market Overview
• 24.2. USA Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Analgesics Market

• 25.1. Canada Analgesics Market Overview
• 25.2. Canada Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Analgesics Market

• 26.1. South America Analgesics Market Overview
• 26.2. South America Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Analgesics Market

• 27.1. Brazil Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Analgesics Market

• 28.1. Middle East Analgesics Market Overview
• 28.2. Middle East Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Analgesics Market

• 29.1. Africa Analgesics Market Overview
• 29.2. Africa Analgesics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Analgesics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Analgesics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Analgesics Market Competitive Landscape And Company Profiles

• 30.1. Analgesics Market Competitive Landscape
• 30.2. Analgesics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medley Pharmaceuticals Limited
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bayer HealthCare Pharmaceuticals LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Analgesics Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Co.
• 31.4. AstraZeneca Plc.
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Takeda Pharmaceutical company Limited
• 31.8. Eli Lilly and Company
• 31.9. Becton Dickinson and Company
• 31.10. Reckitt Benckiser Group plc
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceuticals Industries Ltd.
• 31.13. Boston Scientific Corporation
• 31.14. Sun Pharmaceutical Industries Limited
• 31.15. Purdue Pharma L.P

32. Global Analgesics Market Competitive Benchmarking

33. Global Analgesics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Analgesics Market

35. Analgesics Market Future Outlook and Potential Analysis

• 35.1 Analgesics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Analgesics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Analgesics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer